Contrast-Enhanced MRI for the Characterization of Ductal Carcinoma in Situ (DCIS)

Inclusion Criteria

• •DISEASE CHARACTERISTICS:
• •Meets 1 of the following criteria:
• •* Patients at the University of California, San Francisco Breast Care Center meeting the following criteria:
• •* Biopsy proven ductal carcinoma in situ (DCIS) of the breast.
• •* Has undergone mammography within the past 60 days.
• •* ADH patients: over 18, no prior history of breast disease.
• •PATIENT CHARACTERISTICS:
• •Referrals to this trial are through breast care clinicians only
• •Not pregnant or nursing (or stopped nursing within the past 3 months)
• •Negative pregnancy test
• •No contraindication to MRI (e.g., implanted pacemaker, implanted ferromagnetic device, ferromagnetic aneurysm clip, severe claustrophobia, ocular metal fragments, or shrapnel injury)
• •PRIOR CONCURRENT THERAPY:
• •More than 2 years since prior surgery to the ipsilateral breast (patient)
• •No prior radiotherapy to the ipsilateral breast (patient)
• •No prior cytotoxic regimens (patient)